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Abstract
Background: Private medicine retailers (PMRs) are key partners in the home management of fevers in many settings.
Current evidence on effectiveness for PMR interventions at scale is limited. This study presents evaluation findings of two
different programs implemented at moderate scale targeting PMRs for malaria control in the Kisii and Kwale districts of
Kenya. Key components of this evaluation were measurement of program performance, including coverage, PMR
knowledge, practices, and utilization based on spatial analysis.
Methodology/Principal Findings: The study utilized mixed quantitative methods including retail audits and surrogate client
surveys based on post-intervention cross-sectional surveys in intervention and control areas and mapping of intervention
outlets. There was a large and significant impact on PMR knowledge and practices of the program in Kisii, with 60.5% of
trained PMRs selling amodiaquine medicines in adequate doses compared to 2.8% of untrained ones (OR; 53.5: 95% CI 6.7,
428.3), a program coverage of 69.7% targeted outlets, and a potential utilization of about 30,000 children under five. The
evaluation in Kwale also indicates a significant impact with 18.8% and 2.3% intervention and control PMRs selling
amodiaquine with correct advice, respectively (OR; 9.4: 95% CI 1.1, 83.7), a program coverage of 25.3% targeted outlets, and
a potential utilization of about 48,000 children under five. A provisional benchmark of 7.5 km was a reasonable threshold
distance for households to access PMR services.
Conclusions/Significance: This evaluation show that PMR interventions operationalized in the district level settings are
likely to impact PMR knowledge and practices and lead to increased coverage of appropriate treatment to target
populations. There is value of evaluating different dimensions of public health programs, including quality, spatial access,
and implementation practice. This approach strengthens the potential contribution of pragmatic study designs to
evaluating public health programs in the real world.
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Introduction
The popularity of private medicine retailers (PMRs) in the home
management of fevers in many settings [1,2] has led to the
recognition of their importance for malaria control [3]. However
the current evidence on programme effectiveness for PMR
interventions at scale is limited, making it difficult to define public
health policy for this sector. Moreover the legal status of PMRs
varies, with each country having its own procedures and different
categories of licenses for PMRs. Countries such as Tanzania have
Part I and Part II pharmacies where Part I pharmacies are run by
a registered pharmacist, and are allowed to sell both prescription-
only and over-the-counter (OTC) medicines. Part II pharmacies
also known as drug shops stock a variety of drugs [4]. In many
settings including Kenya, most PMRs are licensed to sell over the
counter (OTC) medicines such as analgesics and antipyretics. In
practice however, many PMRs include other prescription only
medicines such as antimalarials and antibiotics in their stock [5,6].
Kenya has developed a number of malaria control initiatives
targeting PMR practices and use of OTCs medicines in recent
years. Here we present an evaluation of two of these programmes
that encompassed different approaches to PMR interventions:
One undertaken by the Ministry of Health (MoH) and the other
by a Non-Governmental Organization (NGO) in two different
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8937parts of Kenya. The programmes were implemented between
2005 and 2007 as part of scaling up home management of malaria
(HMM) strategy [7], supported in the Kenya National Malaria
Strategy [8].
Methods
Broad Methodological Approach
In evaluating public health interventions, randomised controlled
designs are regarded as gold standard. However, they may not be
feasible, ethical or informative in a variety of situations, including
complex interventions [9,10,11,12]. Habicht and colleagues
provide a useful pragmatic framework for identifying appropriate
evaluation designs. They identify the ‘what’ is to be measured
(provision, utilization, coverage and impact) and the ‘how’ or level
of certainty for inference, from adequacy to plausibility and
probability [9]. These pragmatic designs often incorporate the
concept of plausibility instead of probability, aiming to construct a
strong argument that a measured effect is unlikely to have been
caused by inputs outside a given intervention. Key to the design is
the selection of comparable control groups and rigorous
assessment of the potential effect of any confounders.
The two PMR initiatives evaluated in this study represent
examples of interventions with different elements, including
training, demand creation and quality assurance, and requiring
generation of an enabling environment. We have used Habicht’s
framework, including pragmatic elements dictated by practical
limitations and addressing multiple dimensions of the interven-
tions. Quantitative methods addressed impacts on PMR knowl-
edge and practice and programme coverage and utilisation, while
policy analysis of implementation experiences drew on qualitative
methods. Here we focus on the quantitative elements while the
policy analysis component is presented elsewhere (Abuya et al.,
submitted). Central to the quantitative analysis is the measurement
of programme coverage, potential utilisation, and PMRs’
knowledge and practices, allowing for a multidimensional
perspective of potential public health impacts for these initiatives.
The two PMR programmes were chosen as their different funding
and management structures were of interest to the policy analysis
component of the study. However, it is important to note that the
design of the quantitative analysis component reported on in this
paper does not allow for direct comparisons of these programmes,
but for assessments of impact in each district.
Overview of PMR Programmes Evaluated
The evaluation covered a programme supported by an NGO,
Merlin (Medical Emergency Relief International), in Kisii Central
district in Western Kenya and an MoH programme in Kwale
district in Coast Province. The Kisii programme was characterised
by a highland/epidemic type of malaria transmission [13] while
the Kwale intervention was conducted in an area of endemic
malaria transmission [13]. The Merlin PMR programme was
implemented between 2005 and 2006 under a larger malaria
control programme aiming to reduce morbidity and mortality
associated with malaria through increasing capacity among formal
and informal healthcare providers to diagnose and treat malaria
according to the MoH guidelines. [14]. The Kwale programme
was part of the first steps taken by the Division of Malaria control
(DoMC) towards scaling up the HMM strategy in Kenya
implemented in 2005. The programme aimed to train PMRs to
stock MoH recommended anti-malarials, offer appropriate advice
on the treatment of simple fevers in children with anti-malarials
and educate community members on fever management [15].
Table 1 summarises key programme activities.
Study Design
The evaluations were conducted approximately six months post
implementation in each district. Quantitative assessment of
programme focussed on impact on PMR knowledge and
behaviour, coverage and utilisation. The study designs differed
between the programmes for practical reasons. A retrospective
approach was used in Kisii since the programme was already in
operation in Kiamokama division at the time of evaluation. A
similar division (Suneka) was identified as a contemporaneous
control where Merlin did not implement the programme. Two
divisions in Kwale (Matuga and Kinango) had been randomly
allocated to intervention area, while two others (Msambweni and
Samburu) acted as controls [16]. In both sites, public health and
administration leaders’ knowledge of local malaria control
activities, socioeconomic status, geographical features, malario-
metric indices and access to formal health facilities were used to
identify divisions for the evaluation, either prospectively in the case
Table 1. Key Features of programme activities.
Characteristics Kwale-MoH programme Kisii-Merlin programme
Training Two-day participatory training of PMRs on use of amodiaquine.
Recruitment based on selling anti-malarial medicines, stability of
outlet and positioning in remote settings. Training covered
malaria treatment and control, signs and symptoms of malaria,
signs requiring referral to trained health workers and communi-
cations skills
Three-day participatory training of PMRs on use of amoadiaquine.
Recruitment based on selling antimalarial medicines, stability of
outlet and positioning in remote settings, training covered malaria
treatment an control, signs and symptoms of malaria, signs requiring
referral to trained health workers, communication skills and record
keeping
Demand creation Public information activities through schools, churches and
community distribution of T-shirts with messages on fever
management
Not conducted
Accreditation Paper posters Wooden posters and award of certificates
Motivation Financial token to actors participating in workshops. Per diem allowances of $ 3.7 given to PMRs and $ 5.2 for Public health officers and
District health management teams members participating in the workshops
Monitoring and evaluation Follow ups not conducted Visits to check records, administer quizzes and discuss ways of
solving practical problems
Implementing agencies/
funding
Ministry of health-Global Fund NGO-Merlin in collaboration with ministry of health with funding
from the government of Finland
doi:10.1371/journal.pone.0008937.t001
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Study Methods
Global positioning systems (GPS) mapping and spatial
analyses. To assess coverage and potential utilization, all outlets
in the intervention areas were visited and mapped by field workers
using GPS hand held receivers (Germin etrex and Trimble 12
band GPS units). Field workers then conducted a short interview
on ownership of the outlet, type and brands of antimalarials
available at the time of the survey and their involvement in the
retailer programme. Thereafter, three coordinate readings of the
outlets were recorded, each with the accuracy level of below 20
metres. Coordinates from GPS readings were entered in
MicroSoft excel software and transferred to geographical
information system (GIS) software Arcview GIS 3.2 (ESRI Inc.,
USA) to generate maps. The point data were overlaid with the
polygon features of the intervention division to validate the geo-
positioning of the outlets. To derive threshold distances for
estimating utilisation, the proportion of clients using retail outlets
for a fever in a particular locality was derived from a previous
household survey [17]. Using the enumeration area (EAs) maps in
the programme areas, distance in terms of walking time to visit
each treatment source was derived using a surface model allowing
for terrain [18].
The basic inputs for the model were journey time to the nearest
retail outlet for fever treatment which was represented by a
numeric code (1 for retail outlets and 2 for other options). The
reference table was exported to S-Plus for widows 6.1 version
(Insightful Corporation, Inc., Basingstoke, Hampshire, UK). The
script calculated utilisation rate (UR) at each journey-time interval
which was then smoothened by taking a moving average of 50
minutes for each point interval. The purpose was to assess the
relationship between UR of retail sector users versus all other
sources outside the home using a mathematical function used
previously [18].
Once a threshold distance was derived, an under five population
surface model was developed using the projected under five
population for 2006 (based on the 1999 national census). In this
analysis Thiessen Polygons (TP) were used to generate the
catchment areas for each of the market centres (most outlets in
this setting are either located in small or large commercial centres
or in dotted around villages). TP assigned each point with a retail
outlet and based on the threshold distance, polygon maps of outlet
catchment areas were generated. A population surface for children
under five covering a grid of 100 m by 100 m cell was used to
estimate the number of children in each polygon. The under five
population of all EAs within the centre’s catchment area was
summed as the potential users of the retail outlets.
Retail audit and surrogate client surveys. In the
intervention areas of both districts, 80 study outlets were
randomly sampled from a list of all trained outlets. The type of
outlets available in these settings include general retail stores which
sell a range of OTC medicines such as painkillers and some
antimalarials alongside a range of household goods such as soap,
cooking oil and groceries; general wholesale shops that supply
goods to retail outlets; kiosks and market stalls; and itinerant
hawkers who supply goods and medicines to outlets in the
periphery. A sample size of 60 anti-malarial sales during the study
period was calculated for the evaluation to demonstrate a 20%
difference between control and intervention outlets with 80%
power and 95% confidence intervals, from an estimated 5% of
control outlets showing appropriate practice. An additional 20
sales were added to allow for data losses [19]. In the control group,
a list of all outlets selling anti-malarial medicines was developed by
local public health staff. Randomisation in control and
intervention areas was conducted using STATA version 8 (Stata
Corp, College Station, Texas, USA).
Six local field workers per division were recruited and trained
for the surrogate client survey (SCS) and retail audit. The SCS was
conducted first, during which field workers visited study outlets in
both the control and intervention areas and requested an anti-
malarial medicine for a child. Where asked for more information,
they provided standardised responses to questions about the age of
the child (three years), the symptoms of the illness (fever only) and
any previous treatment given (none). Each visited outlets away
from their own homes to avoid local recognition. Details of the
transaction were entered in a simple form.
Following the SCS, a retail audit of all outlets visited during the
SCS were conducted to collect information on general character-
istics of the outlets and PMRs, drugs stocked; retailers’ knowledge
and reported practices through a vignette which sought to assess
the selling practices on malaria medicines stocked; and their
referral practices for a five year old child. Before each interview,
the field workers gave a careful explanation of the purpose of the
survey and sought verbal consent from the main seller. A pre-
tested structured questionnaire was used to collect the information.
All the quantitative data from the surrogate client survey and
retail audit were checked for errors and coded each day.
Assessment of adequateness of advice of anti-malarial medicines
was based on the national malaria guidelines. Data were double
entered using FoxPro Version 6 software (Microsoft Corp,
Redmond, USA). Verification, cleaning and analysis was con-
ducted using STATA version 8 (Stata Corp, College Station,
Texas, USA). Analysis within each district was done using chi–
square tests of association to compare proportions for key outcome
indicators. Where differences between the control and intervention
areas were observed, a logistic regression model was used to
estimate the magnitude of effect. The outcomes are presented as
odds ratios derived from random effect model (using xtlogit
command).
Ethical Considerations
The study was approved by the Kenya National Scientific
Steering and Ethical Research Committees (KEMRI SCC no
1056). Verbal informed consent was sought for the retail audit and
mapping study. Given the nature of the method, informed consent
could not be sought from PMRs for the surrogate client survey.
Seeking consent for this study would have undermined the
purpose of the study. Consent was thus obtained from community
leaders and permission for an individual informed consent waiver
was granted by the national ethics review committee.
Results
Programme Coverage
Figure 1 (a-b) shows the spatial distribution of retail outlets and
health facilities in relation to population densities and transport
networks. Population distribution in Kisii was more evenly
distributed than that in Kwale (Figure 1a). The highest coverage
of trained outlets was observed in Kiamokama division of Kisii, with
83/306 (27.1%) outlets trained compared to all divisions (Table 2).
In Kwale, Figure 1.1b shows that most of the trained outlets were
clustered around the coastal strip and major market centres. The
programme covered 96/679 (14.1%) of all outlets with variations at
the divisional level. However, Table 2 illustrates that overall many
outlets in both districts did not stock anti-malarials (60.6% in Kisii
and 43.9% in Kwale). The proportion of ‘true’ programme target
Medicine Retailers in Kenya
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69.7% in Kisii and 25.3% in Kwale.
Potential Utilization of PMR Services
Results in this section were derived from modelling utilisation
rates of retail outlets for fever treatment against all other treatment
sources. Figure 2 illustrates the output of the analysis of threshold
distance (considered as the minimum distance a care giver is likely
to travel to access PMRs services). The y-axis shows the proportion
of patients (under five) who used retail outlets at each interval
while the x-axis shows predicted travel times in minutes to the
outlets. The parameter C in Figure 2 represents the distance
within which most caregivers would use the retail outlets. This
parameter was 90 minutes, translating to a travel distance of
7.5 km (assuming a walking rate of 5 km/hour). The 7.5 km
threshold distance was then used to estimate the underlying under
five population likely to use trained retail outlets. Based on the
threshold distance, the average travel distance to a centre with a
programme outlet (trained outlet) was 1.30 km in Kisii and
1.86 km in Kwale. However, there were variations at divisional
level in Kwale with Matuga division having an average travel
distance of 1.05 km compared to 2.66 km in Kinango division.
Taking both Kwale divisions together, the programme covered a
potential target population of 47,785 children under five years.
Potential utilisation in the remote rural division of Kinango
(39,525 children) was higher than that for Matuga division (8,260
children) (Table 2). The Kisii programme (one division) had a
potential utilisation of 29,876 children under five.
Figure 1. Maps of study sites showing population distribution, retail outlets, health facilities and transport networks. The first map
shows projected population densities for 2006 in each enumeration area (EA). The second map combines retail outlets, health facilities and transport
networks.
doi:10.1371/journal.pone.0008937.g001
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Characteristics
Kisii site: Kiamokama
division Kwale site
Matuga division Kinango division Both divisions
Coverage of programmes
Outlets in division 331 391 318 709
Open outlets/all outlets 306/331 (92.4%) 387/391 (98.9%) 291/318 (91.8%) 679/709 (95.8%)
Trained outlets/all open outlets 83/306 (27.1%) 42/387 (10.9%) 54/291 (18.5%) 96/679 (14.1%)
Outlets with anti malarial/open outlets* 119/302 (39.4%) 251/387 (64.9%) 128/291 (43.9%) 379/676 (56.1%)
Trained outlets/all outlets with antimalarials 83/119 (69.7%) 42/251 (16.7%) 54/128 (42.2%) 96/379 (25.3%)
Health facilities and population distribution
Health facilities 9 4 4 8
Area 161 Km
2 341 Km
2 1842 Km
2 2183 Km
2
Population projections by 2006{ 121 844 86 284 86 405 172 689
Population density 757 persons/ Km
2 253 persons/Km
2 47 persons/ Km
2 79 persons/ Km
2
Projected under five 18 226 12 781 15 897 28 678
Under five population potentially reached{{ 29876 8260 39575 47785
Population service indices
PMR: population 1:368 1:220 1:272 1:243
PMR: under five population 1:56 1:33 1:50 1:40
Trained PMR: population 1:1007 1:2054 1:1600 1:1798
Trained PMR: under five population 1:219 1:304 1:294 1:299
Health facility: population 1:13538 1: 21571 1::10800 1:21608
Health facility: trained PMR 1:9 1:9 1:8 1:12
*there were a number of outlets where information on anti-malarial medicines in stock could not be established, for example availability of anti-malarial in trained outlets
could not be established in 2 outlets in Kisii, and 1 in Kwale respectively.
{population projections for 2006 are based on the 1999 census at an intercensal growth rate of 2.0% in Kisii and 2.6% in Kwale.
{{This includes under fives living within 7.5 km of a trained outlet which may overlap with neighbouring areas.
doi:10.1371/journal.pone.0008937.t002
Figure 2. Graph showing utilization rates of retail sector services for treatment of fevers in the Kisii site. Summarises the output of the
assessment of threshold distance to access retail sector services.
doi:10.1371/journal.pone.0008937.g002
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From the retail audit, 68.1% of intervention outlets in Kisii and
56.5% in the control areas stocked anti-malarial medicines. In
Kwale these were 53.2% and 67.3% in the intervention and control
areas respectively. These data differ from those shown for the GPS
survey, since the sampling frame for the retail audit included target
outlets for the programme and control outlets likely to stock anti-
malarial medicines, from local knowledge. Most outlets surveyed
were general retail shops run by one retailer. In terms of gender,
education and age, PMRs were similar in the control and
intervention areas in all sites. Most PMRs were relatively young
(,35 years) and had between 8 and 12 years of schooling.
Figure 3 shows that a majority of all outlets with antimalarials
stocked the MoH recommended drug, AQ, and this was not
significantly different between control and intervention areas. In
Kisii 96.7% of intervention outlets that stocked antimalarials
stocked AQ medicines compared to 86.5% in the control area,
p,0.023. In Kwale, these proportions were 92.0% in intervention
and 87.8% in the control areas, p=0.559. Table 3 illustrates levels
of PMR knowledge on the use of OTC antimalarials. 79.3% of
trained and 16.7% of control PMRs in Kisii knew the correct
dosage for AQ (OR; 18.6: 95% CI 6.6, 52.2) while 48.8% of
trained and no control PMRs were able to provide this
information in Kwale. A common pattern for incorrect use in
both districts was administration of AQ for one day. In both
districts, there were no statistically significant differences between
the control and intervention areas in the proportion of PMRs who
had correct knowledge on the dosage of SP medicines.
Table 4 presents data on PMRs’ anti-malarial selling practices.
When asked by a surrogate client for an anti-malarial medicine for
a young child, over half of PMRs sold anti-malarial medicines in
all sites. Anti-malarial medicines were more often sold in the
intervention compared to the control outlets in Kisii (OR; 4.4:
95% CI 1.1, 17.9) and Kwale (OR; 4.4: 95% CI 1.4, 13.8) but this
was not statistically significant. As a proportion of all anti-malarial
sales, 60.5% of trained PMRs sold AQ medicines accompanied
with adequate advice on use compared to 2.8% of untrained
PMRs in Kisii (OR; 53.5: 95% CI 6.7, 428.3). In Kwale, these
percentages were 18.8% in the intervention and 2.3% in the
control outlets (OR; 9.4: 95% CI 1.1, 83.1).
Discussion
The main aim of this paper is to describe the potential
contributions of two different PMR programmes to malaria
control in Kenya, based on measurements of dimensions of
performance (coverage, knowledge and practices of PMRs and
potential utilisation). This evaluation indicates a large and
significant impact on PMR knowledge and practices of the
programme in Kisii, with 60.5% of trained PMRs selling AQ
medicines in adequate doses compared to 2.8% of untrained ones
(OR; 53.5: 95% CI 6.7, 428.3), a programme coverage of 69.7%
targeted outlets and a potential utilisation of 29,876 children under
five. In Kwale a significant impact was observed with 18.8% and
2.3% intervention and control PMRs, respectively, selling AQs
medicines in adequate doses (OR; 9.4: 95% CI 1.1, 83.7), a
programme coverage of 25.3% targeted outlets and a potential
Figure 3. Proportion of outlets with anti-malarial medicines
that stocked amodiaquine.
doi:10.1371/journal.pone.0008937.g003
Table 3. PMR’s knowledge on dosing SP and AQ medicines for under fives.
Adequacy on dosages for anti-
malarial medicines recommended Kisii site Kwale site
I n (%) C n (%) P OR (95% CI) I n (%) C n (%) P OR (95% CI)
Dosing of AQ medicines available*
Recommended AQ adequately 46/58 (79.3%) 7/42 (16.7%) ,0.001 18.6 (6.6, 52.2) 21/43 (48.8%) 0/58 (0%) 1.000 na
Recommended AQ in over dose 3/58 (5.2%) 17/42 (40.5%) ,0.001 0.08 (0.2, 0.3) 12/43 (27.9%) 18/58 (31.0%) 0.734 0.9 (0.3, 2.4)
Recommended AQ in under dose 8/58 (13.8%) 17/42 (40.5%) 0.002 0.2 (0.08, 0.6) 10/43 (23.3%) 34/58 (58.6%) ,0.001 0.2 (0.1, 0.5)
Recommended AQ for one day 8/58 (13.8%) 19/42 (45.2%) ,0.001 0.2 (0.07, 0.5) 3/43 (6.9%) 34/58 (60.3%) ,0.001 0.03 (0.004, 0.3)
Dosing of SP medicines available
Recommended SP adequately 1/5 (20.0%) 8/20 (40.0%) 0.405 0.4 (0.04, 3.9) 11/23 (47.8%) 14/32 (43.7%) 0.765 1.2 (0.4, 3.4)
Recommended SP in high dose 4/5 (80.0%) 12/20 (60.0%) 0.621 2.7 (0.3, 28.4) 6/23 (26.1%) 10/32 (31.2%) 0.678 0.8 (0.2, 2.6)
Recommended SP in low dose 0/5 0/20 NA NA 6/23 (26.1%) 8/32 (25.0%) 0.927 1.1 (0.3, 3.6)
Recommended SP for three days 4/5 (80.0%) 6/20 (30.0%) 0.121 9.3 (0.9, 101.2) 11/23 (47.8%) 3/32 (9.4%) 0.002 8.9 (2.1, 37.5)
Throughout this paper the following labels apply to all the tables. I = intervention area (Kiamokama in Kisii and Kinango and Matuga in Kwale); C=
control area (Suneka of Kisii and Msambweni and Samburu of Kwale) = P value for comparison of intervention and control in each site; OR = odds
ratio of the comparison between control and intervention in each site.
{Use of NA -represents cases where that measure was not applicable or could not be derived.
doi:10.1371/journal.pone.0008937.t003
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utilisation in Kinango division of Kwale district (39,525 children),
a remote rural area typical of sites where access to health care is of
particular concern. We also suggest that a provisional benchmark
of 7.5 km is a reasonable threshold distance for households to
access PMR services, although further studies are important to
examine this finding in different settings.
Use of different methods as part of this assessment provides a
main strength for this evaluation. Further advantages include the use
of contemporaneous controls for knowledge and practice surveys [4]
and the close relationship between the intervention itself (training on
over the counter anti-malarials) and the outcomes measured
(knowledge and practice on the use of these anti-malarials).
However, an important limitation is the timing of this evaluation,
providing little evidence for sustainability of the changes measured.
Data on sustainability remain scanty once the involvement of
researchers or donors has ceased [4]. In addition, given the
pragmatic nature of this evaluation, there are other potential
limitations to interpretation that are important to consider.
Pragmatic Approaches to Minimise Study Limitations
Randomisation and replication were either limited or not
possible in these sites. In Kisii, this could not be achieved due to
the retrospective nature of this evaluation of an on-going
programme. In Kwale, while the evaluation could draw on a
prospective cluster randomised design, the district level analysis
was affected by the availability of only two interventions and two
control areas. Use of a single survey was a further complication in
interpreting the data. Without a historical control, it was not
possible to establish whether differences (or similarities) between
contemporaneous controls and interventions existed before the
intervention, or result from the intervention.
In order to limit the effect of potential confounders, control
areas were selected carefully taking into account local knowledge of
factors considered important potential confounders, including
access to formal health care, socio-economic factors, malaria
burden and geographical location. Malaria, or at least fever,
prevalence was a potential confounder, with higher levels being
feasibly associated with greater use of anti-malarials, both at the
outlet stocking and consumer levels, since these are related through
demand. Although Plasmodium falciparum rates are very different in
the two districts, at 67.5% in Kwale and 27.5% in Kisii, controls
and interventions were chosen with similar rates in each district, as
gauged by health officials from clinic and hospital records.
Data on the number of PMRs per outlet, gender, education and
age of PMRs indicated comparability of the intervention and
control areas in both districts. These factors, particularly
educational status, were considered important potential sources
of bias or confounding for an educational intervention. The
number of PMRs per outlet was considered an important indicator
of the size and economic viability of outlets [20,21]. Similarities in
all these features suggest that differences in the main outcomes
measured were unlikely to have been influenced by different
characteristics of the retail sector in these settings.
PMR practices were assessed through the SCS which, although
frequently used and recommended for evaluating provider
performance, is open to bias. The SCS is limited in terms of
standardization of information, which potentially undermines the
reliability of the results [22]. A further drawback of this method is
inflexibility, including the inability to probe to uncover reasons
behind any observed behaviours. For example, unexplained data
loss was experienced during the SCS because of relatively high
rates of PMRs refusing to sell over the counter medicines; (60.6%
and 39.6% in Kisii; 41.6% versus 42.4% in Kwale from the
intervention and control areas respectively). Reasons for these
refusals were difficult for surrogate clients to explore without
revealing their identity. Low numbers of observations in the SCS
also limited the analysis, resulting from the low numbers of outlets
trained, particularly in Kwale, the generally low levels of stocking
anti-malarial and the tendency for PMRs to prefer not to sell anti-
malarial medicines for young children; this finding being
confirmed qualitatively. During the retail audit, response bias
may have led to PMRs reporting practices that they assumed to be
‘‘desirable’’ rather than those they actually undertake, and thus to
over reporting of correct practices. In addition, field workers were
not blinded to the control or intervention group which may have
influenced information recorded.
Efforts were made to minimise these sources of bias. Surrogate
clients were trained using a skills based approach to support
standardisation of information given to PMRs, data was collected
on simple standardised collection forms and work reviewed every
three days. To limit the chances of surrogate clients being
recognised, field workers were recruited locally but visited outlets
outside their normal locations. This meant working outside
Table 4. PMR’s practices while selling medicines for a three year old febrile child.
Selling practices Kisii site Kwale site
I (n) % C (n) % P OR (95% CI) I (n) % C (n) % P OR (95% CI)
Sold anti-malarial with or without
antipyretic*
40/43 (93.0%) 27/36 (75.0%) 0.032 4.4 (1.1, 17.9) 27/32 (84.4%) 23/42 (54.7%) 0.011 4.4 (1.4, 13.8)
Sold antipyretic only 3/43 (6.9%) 9/36 (25.0%) 0.026 0.2 (0.1, 0.9) 5/32 (15.6%) 19/42 (45.2%) 0.011 0.2 (0.1, 0.7)
Type of anti-malarial sold and adequacy of dosage{
Sold AQ 38/43 (88.4%) 20/36 (55.6%) 0.002 6.1 (1.9, 19.0) 19/32 (59.4%) 8/42 (19.1%) ,0.001 6.2 (2.2, 17.7)
Sold AQ with adequate advice 26/43 (60.5%) 1/36 (2.8%) ,0.001 53.5 (6.7, 428.3) 6/32 (18.8%) 1/42 (2.3%) 0.038 9.4 (1.1, 83.1)
Sold AQ with adequate advice on dose/
all AQ sold
26/38 (68.4%) 1/20 (5.0%) ,0.001 41.2 (4.9, 344.4) 6/19 (31.6%) 1/8 (12.5%) 0.633 3.3 (0.3, 33.9)
Sold SP 2/43 (4.7%) 8/36 (22.2%) 0.037 0.2 (0.03, 0.9) 8/32 (25.0%) 15/42 (35.7%) 0.324 0.6 (0.2, 1.7)
Sold SP with adequate advice 0/36 (0%) 5/36 (13.8%) 0.017 NA 4/32 (12.5%) 8/42 (19.0%) 0.536 0.6 (0.2, 2.2)
*Note: the denominator was all medicines sold.
{the denominator is the outlets where either SP or AQ medicines were available at the time of the survey.
doi:10.1371/journal.pone.0008937.t004
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Although field workers were oriented with maps in advance,
getting lost remained a logistical problem and a potential source of
bias. All the above processes drew on experience with this method
in other districts [19,23].
There are also caveats to the interpretation of GPS mapping
data and spatial analysis. Generally, using provider-population
ratios ignores overlaps in potential border crossing between
polygons by patients and instead assumes homogeneity in utility
[24]. The approach does not incorporate measures of distance
dimension [25] and spatial access was therefore measured using a
Euclidean model. A limitation of this method is that catchment
areas are delineated using TP techniques based on an assumption
that patients choose the nearest retail outlet regardless of the type
and services offered. However, in practice only a certain
proportion will use retail sector services. Furthermore we did not
have data from household data to examine actual utilization and
factors influencing patient choice for different providers. This
would have provided useful insights on how household level factors
including patient choices may have influenced utilization.
Implications for Policy
In common with previous research on interventions in this
sector, and with the caveats described above, the study illustrates a
potential for improving PMR behaviour through training and
public information. A recent review showed that PMR interven-
tions lead to greater knowledge, improved practices of PMRs and
a higher rate of appropriate treatment of malaria and other
childhood illnesses among communities [4]. For example, studies
in Uganda indicate that the proportion of drugs stores giving
appropriate drugs for uncomplicated malaria increased from 2%
to 73% after negotiated sessions while those that recommended
correct anti-malarial doses (CQ and SP) increased from 0% to
49% [26]. In Nigeria training and pre-packaging of antimalarials
has been reported to lead to an increased proportion recom-
mending correct anti-malarial doses from 9% to 53% [27]. In
Kenya, 86% of PMRs gave appropriate advice on anti-malarial
(CQ) after training compared to 0% on the untrained areas [23].
The study provides novel information on the potential
programme coverage and utilisation, using modelling of GPS
data. Use of spatial analysis in this study showed that despite low
coverage of outlets and the highest physical distance to access a
trained PMR, the Kwale site demonstrated a relatively high
potential utilisation of target group compared to Kisii, and that
this was primarily achieved in the more remote and sparsely
populated division of Kinango. GPS mapping and spatial analysis
have therefore provided insights into variations in the potential
utilisation of programmes that are unable to be quantified from
assessing simple proportions of outlets reached. However, further
work is recommended on how spatial data can be used to assess
the potential to reach different socio-economic groups.
Use of the TP approach also supports a more effective
assessment of programme functioning than knowledge and
practice surveys alone. For example, although the coverage of
trained outlets with antimalarials may appear low in Kwale with
only 25.3% of outlets with antimalarials being reached in Kwale
and 69.7% in Kisii, the under five catchment population is likely to
be high given the population distribution in these settings.
Assuming community members use PMRs as a first source of
treating simple fevers, if 60.5% of trained PMRs in Kisii sold AQ
medicines in adequate doses, this would translate to about 18,074
children receiving adequate treatment if their caregivers sought
care from trained PMRs. In comparison, in Kwale, 18.8% of
trained PMRs sold AQ medicines adequately, translating into
8994 under fives who could receive adequate treatment. Such an
assessment emphasises that ‘effective’ coverage needs a balance
between coverage and quality of implementation.
Since 2007, the MoH first line recommended anti-malarial for
use in the formal sector has been artemesinin combination therapy
(ACTs). Pilot studies have been conducted in Kenya and elsewhere
in sub Saharan Africa on their deployment in the private retail
sector [28]. The findings on coverage in this study are of relevance
to the debate on the feasibility and potential effectiveness of
introducing ACTs into this sector. A key challenge for costly ACT
medicines for the retail sector is affordability, both from a demand
and supply perspective. Studies have shown previously that PMRs
are often more likely to stock antipyretic than anti-malarial
medicines for this reason [16,23,29], presenting a challenge to
arguments that PMRs provide a sustainable channel to increase
access to early effective treatment for malaria. The coverage data in
this study suggests that a high proportion of even remote rural
outlets can stock anti-malarial medicines (such as in Kinango), and
that even the very low levels of programme implementation seen in
these areas may support important utilisation for children under
five years. This implies that the current commercial pricing of over
the counter anti-malarials, such as AQ and SP, may in some
situations act as a guide to the levels of subsidy needed for ACTs in
this sector, and supports the current global efforts on subsidies [30].
As previously described, this study was not designed to compare
outcomes quantitatively between the two programmes. The
differences in knowledge gained, skills practised and outlet
coverage do however look striking. Qualitative approaches,
drawing on health policy analysis frameworks, support these as
real differences and identify the likely contributing factors. These
findings have been reported separately (Abuya et al, submitted)
but, in summary, are linked to implementation gaps and
challenges in managing the implementation process.
Conclusions
Whilst it does not address sustainability, the study supports the
findings of others in showing the potential for interventions based
on participatory training and communication to improve the
knowledge and skills of PMRs in selling anti-malarial drugs. A
specific and relatively novel approach has been provided by using
GIS as part of this evaluation. Spatial data have highlighted
specific challenges around programme coverage as well as
indicating the potential usefulness of even relatively low coverage
levels in remote rural areas, depending on patterns of population
distribution. While needing further research to support this
finding, the technique proposes a specific distance of 7.5 km that
could be used in measuring access to programme outlets. The
spatial analysis of antimalarial coverage in both control and
intervention outlets in these two districts also provides some
evidence for price setting for subsidised ACTs in future, and
supports current Affordable Medicines for malaria (AMFm)
strategies in other malaria endemic countries. Overall, the study
illustrates the value of using different dimensions of programme
functioning to assess performance, including quality, spatial access
and implementation practice. This multi-dimensional strengthens
the contribution of pragmatic study designs to evaluating public
health programmes in the real world.
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